| |||||||
|
Technologies, Markets, & Opportunities By Pamela Bassett, D.M.D., M.B.A. Published: January, 2003 250+ Pages, 55+ Exhibits, 39 Companies Profiled The cell therapy market will near $30 billion by 2010 Cell therapy, the transplantation of living cells for the treatment of medical disorders, is a rapidly growing market estimated to reach $30 billion by 2010. D&MD's Cell Therapy: Technology, Markets & Opportunities describes the strategies and technologies corporations are employing to capture their share of this growing market. This informative Report answers many important questions, including what diseases will significantly benefit from current and future research, how regulatory and ethical hurdles will come into play, and which corporations are poised to win. D&MD's Cell Therapy highlights the current mergers, acquisitions, licenses and alliances in this space with their corresponding market strengths. In addition, this comprehensive report examines the underlying reasons for growth in each market segment and highlights those companies best poised to capitalize on that growth. Key technologies and methods driving emerging opportunities are also discussed. Unique Benefits of this Report: Keep up with consolidation through analysis of competitive advantages gained from patent and/or technology acquisitions and other licensing and alliance agreements. Make the right decisions between off-the-shelf or personalized medicine therapies with discussions on which approach will ultimately win market share Focus on product acceptance from reimbursement specialists and physicians as therapies are examined for ease of use and patient compliance Review regulatory requirements via discussions on the FDA process for established and new delivery technologies for cell therapy products Stay up to date on key technologies and resources required for product development and manufacturing of cell therapy products Keep an eye on the competition with in-depth profiles of leading cell therapy companies and how they are positioned to take advantage of this growing market. Publisher: Drug and Market Development To order go to this URL: http://www.bioportfolio.com/cgi-bin/acatalog/DMD_2003.html#a58
|
|